[A comparative evaluation of the immune status of patients with squamous-cell cancer of the oral mucosa at different stages of combined treatment].

Shifts in immunity values were detected in 160 patients with oral cancer before specific therapy and at all stages of multiple-modality treatment. High diagnostic significance of measuring concentrations of circulating immune complexes in the serum for prediction of tumor relapse or metastases is demonstrated.